IRadimed Corporation (IRMD) — Financial statements
Income statement, balance sheet, and cash flow for IRadimed Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 84↑14.4% | 73↑11.7% | 66↑23.0% | 53↑27.5% | 42 | |
| Cost of Revenue | 19↑15.4% | 17↑9.7% | 15↑28.1% | 12↑23.1% | 10 | |
| Gross Profit | 64↑14.2% | 56↑12.3% | 50↑21.5% | 41↑28.8% | 32 | |
| Operating Expenses | ||||||
| R&D Expenses | 3↑5.1% | 3↓0.9% | 3↑25.5% | 2↑19.6% | 2 | |
| General & Administrative Expenses | 18↑11.6% | 16↑5.4% | 15↑41.4% | 11↑9.5% | 10 | |
| Selling & Marketing Expenses | 17↑11.5% | 16↑28.6% | 12↓4.2% | 13↑20.1% | 11 | |
| SG&A Expenses | 35↑11.6% | 32↑15.7% | 27↑16.6% | 23↑15.0% | 20 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 38↑11.0% | 34↑14.1% | 30↑17.4% | 26↑15.4% | 22 | |
| Total Costs & Expenses | 58↑12.5% | 51↑12.6% | 46↑20.8% | 38↑17.7% | 32 | |
| Operating Results | ||||||
| Operating Income | 26↑19.0% | 22↑9.6% | 20↑28.2% | 16↑59.2% | 10 | |
| Depreciation & Amortization | 2↑191.1% | 0.82↑6.9% | 0.77↑14.1% | 0.67↓52.3% | 1 | |
| EBITDA | 29↑25.2% | 23↑9.5% | 21↑27.6% | 16↑45.2% | 11 | |
| EBIT | 26↑19.0% | 22↑9.6% | 20↑28.2% | 16↑59.2% | 10 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↓100.0% | 2↑17.7% | 2↑220.4% | 0.58↑1571.7% | 0.03 | |
| Interest Income | 0.00↓100.0% | 2↑17.7% | 2↑220.4% | 0.58↑1571.7% | 0.03 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 2↓4.2% | 2↑35.7% | 2↑207.9% | 0.55↑2872.9% | 0.02 | |
| Income Before Tax | 28↑16.8% | 24↑11.7% | 22↑34.3% | 16↑64.5% | 10 | |
| Income Tax Expense | 6↑16.7% | 5↑10.9% | 5↑35.6% | 3↑556.3% | 0.51 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 22↑16.9% | 19↑11.9% | 17↑34.0% | 13↑37.6% | 9 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 22↑16.9% | 19↑11.9% | 17↑34.0% | 13↑37.6% | 9 | |
| Bottom-Line Net Income | 22↑16.9% | 19↑11.9% | 17↑34.0% | 13↑37.6% | 9 | |
| EPS (Basic) | 1.77↑16.4% | 1.52↑11.8% | 1.36↑33.3% | 1.02↑34.2% | 0.76 | |
| EPS (Diluted) | 1.75↑16.7% | 1.50↑11.1% | 1.35↑32.4% | 1.02↑37.8% | 0.74 | |
| Weighted Average Shares | 13↑0.4% | 13↑0.5% | 13↑0.3% | 13↑1.8% | 12 | |
| Weighted Average Diluted Shares | 13↑0.6% | 13↑0.5% | 13↑0.7% | 13↑0.4% | 13 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.